WO2026069112 - COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS, CHEMOTHERAPEUTIC AGENTS, AND ANTI-FIBROTIC AGENTS
National phase entry is expected:
Publication Number
WO/2026/069112
Publication Date
02.04.2026
International Application No.
PCT/IB2025/059516
International Filing Date
22.09.2025
Title **
[English]
COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS, CHEMOTHERAPEUTIC AGENTS, AND ANTI-FIBROTIC AGENTS
[French]
COMPOSITIONS, SYSTÈMES ET MÉTHODES DE TRAITEMENT DU CANCER À L'AIDE DE CHAMPS DE TRAITEMENT DE TUMEUR, D'AGENTS CHIMIOTHÉRAPEUTIQUES ET D'AGENTS ANTI-FIBROTIQUES
Applicants **
NOVOCURE GMBH
Inventors
LAVY-SHAHAF, Gitit
VOLOSHIN-SELA, Tali
AVIGDOR, Lilach
Priority Data
63/699,469
26.09.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2110 | |
| EPO | Filing, Examination, Granting | 8406 | |
| Japan | Filing, Examination, Granting | 2154 | |
| South Korea | Filing, Examination, Granting | 2066 | |
| USA | Filing, Examination, Granting | 5340 |
Total:
20,076
Contact Us
Abstract[English]
Compositions, systems, and methods for reducing viability of cancer cells and treating cancer, as well as preventing an increase of volume of a tumor present in a body of a living subject, are disclosed. The systems and methods involve application of an alternating field concurrently with administration of at least one chemotherapeutic agent and at least one anti-fibrotic agent.[French]
L'invention concerne des compositions, des systèmes et des procédés pour réduire la viabilité de cellules cancéreuses et traiter le cancer, ainsi que pour prévenir une augmentation du volume d'une tumeur présente dans un corps d'un sujet vivant. Les systèmes et les procédés impliquent l'application d'un champ alternatif simultanément à l'administration d'au moins un agent chimiothérapeutique et d'au moins un agent anti-fibrotique.